Daniel A Vallera

Professor, Radiation Oncology

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

Dive into the research topics where Daniel A Vallera is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

33 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

7 Active
20 Finished

A Novel Approach Combining Oncolytic Virotherapy and Dual Immune Checkpoint Blockade for Metastatic Osteosarcoma
Modiano, J., Henson, M. S., Kim, J. H., Vallera, D. A. & Weigel, B. J.
U.S. DEPARTMENT OF DEFENSE
9/1/20 → 8/31/22
Project: Research project
Strategic Prevention of Canine Hemangiosarcoma: Lifetime Follow-Up
Modiano, J., Borgatti, A. M., Dickerson, E. B., Henson, M. S., Kim, J. H. & Vallera, D. A.
AKC Canine Health Foundation
8/1/20 → 7/31/24
Project: Research project
Driving Natural Killer Cell Immunotherapy in the Castration Resistant Prostate Cancer Setting with Novel Tri-Specific Killer Engager Molecules
Felices, M., Miller, J. S., Rao, A., Ryan, C. & Vallera, D. A.
U.S. DEPARTMENT OF DEFENSE
8/1/20 → 7/31/23
Project: Research project
Enhanced NK cell Immunotherapy for treatment of chemorefractory sarcoma
Vallera, D. A., Lawrence, J. & Terezakis, S.
SARCOMA FDN OF AMER
7/1/20 → 6/30/21
Project: Research project
IL-15 TRiKES-based immunotherapy of TBC; resistance mechanists
Vallera, D. A.
MASSACHUSETTS GENERAL HOSPITAL
8/1/18 → 7/31/21
Project: Research project

208 Article
15 Review article
2 Chapter
1 Editorial
More
- 1 Letter
- 1 Short survey

A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells
Arvindam, U. S., van Hauten, P. M. M., Schirm, D. K., Schaap, N., Hobo, W., Blazar, B. R., Vallera, D. A., Dolstra, H., Felices, M. & Miller, J. S., 2020, (Accepted/In press) In: Leukemia.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Bispecific targeting of EGFR and urokinase receptor (uPAR) using ligand-targeted toxins in solid tumors
Oh, F., Modiano, J. F., Bachanova, V. & Vallera, D. A., Jun 2020, In: Biomolecules. 10, 6, p. 1-13 13 p., 956.
Research output: Contribution to journal › Review article › peer-review

Open Access
Delineation of target expression profiles in CD34¹/CD38² and CD34¹/CD38¹ stem and progenitor cells in AML and CML
Herrmann, H., Sadovnik, I., Eisenwort, G., Rülicke, T., Blatt, K., Herndlhofer, S., Willmann, M., Stefanzl, G., Baumgartner, S., Greiner, G., Schulenburg, A., Mueller, N., Rabitsch, W., Bilban, M., Hoermann, G., Streubel, B., Vallera, D. A., Sperr, W. R. & Valent, P., Oct 21 2020, In: Blood Advances. 4, 20, p. 5118-5132 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma
Borgatti, A., Fieberg, A., Winter, A. L., Stuebner, K., Taras, E., Todhunter, D., Masyr, A., Rendhal, A., Vallera, D. A., Koopmeiners, J. S. & Modiano, J. F., Dec 2020, In: Veterinary and Comparative Oncology. 18, 4, p. 664-674 11 p.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
NK-cell-mediated targeting of various solid tumors using a B7-H3 tri-specific killer engager in vitro and in vivo
Vallera, D. A., Ferrone, S., Kodal, B., Hinderlie, P., Bendzick, L., Ettestad, B., Hallstrom, C., Zorko, N. A., Rao, A., Fujioka, N., Ryan, C. J., Geller, M. A., Miller, J. S. & Felices, M., Sep 2020, In: Cancers. 12, 9, p. 1-18 18 p., 2659.
Research output: Contribution to journal › Article › peer-review

Open Access